Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)
China
· Delayed Price · Currency is CNY 26.28
-0.56 (-2.09%)
At close: Mar 9, 2026
SHA:688443 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Net Income | - | -797.27 | -801.32 | -576.37 | -322.13 | Upgrade
|
| Depreciation & Amortization | - | 66.65 | 59.17 | 49.94 | 38.5 | Upgrade
|
| Other Amortization | - | 7.94 | 4.61 | 3.69 | 5.56 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 0 | - | -0 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 0.54 | 0 | 0 | 0.7 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -2.73 | -1.94 | -7.86 | -4.13 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 0.63 | - | - | -0.03 | Upgrade
|
| Other Operating Activities | - | 29.51 | 34.01 | 33.99 | 32.15 | Upgrade
|
| Change in Accounts Receivable | - | -40.88 | 9.88 | -7.71 | -105.1 | Upgrade
|
| Change in Inventory | - | 4.69 | 1.85 | -22.67 | -17.81 | Upgrade
|
| Change in Accounts Payable | - | 1.73 | 51.1 | 55.87 | 131.8 | Upgrade
|
| Change in Other Net Operating Assets | - | 153.76 | 265.07 | 293.47 | 2.68 | Upgrade
|
| Operating Cash Flow | - | -575.44 | -377.58 | -177.64 | -237.82 | Upgrade
|
| Capital Expenditures | - | -45.32 | -90.98 | -146.21 | -112.7 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.04 | - | - | 0 | Upgrade
|
| Investment in Securities | - | -382.28 | 211.6 | 194.2 | -409.24 | Upgrade
|
| Other Investing Activities | - | 0.14 | - | 3.4 | 1.12 | Upgrade
|
| Investing Cash Flow | - | -427.42 | 120.62 | 51.4 | -520.82 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 73.32 | Upgrade
|
| Long-Term Debt Issued | - | 212.91 | 109.63 | 208.35 | 186.79 | Upgrade
|
| Total Debt Issued | - | 212.91 | 109.63 | 208.35 | 260.11 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -499.15 | Upgrade
|
| Long-Term Debt Repaid | - | -23.39 | -257.25 | -14.88 | -9.07 | Upgrade
|
| Total Debt Repaid | - | -23.39 | -257.25 | -14.88 | -508.22 | Upgrade
|
| Net Debt Issued (Repaid) | - | 189.52 | -147.62 | 193.48 | -248.11 | Upgrade
|
| Issuance of Common Stock | - | - | 3,308 | - | 1,000 | Upgrade
|
| Repurchase of Common Stock | - | -14.68 | - | - | - | Upgrade
|
| Common Dividends Paid | - | -28.67 | -35.02 | -32.1 | -21.59 | Upgrade
|
| Other Financing Activities | - | - | -25.41 | - | - | Upgrade
|
| Financing Cash Flow | - | 146.17 | 3,100 | 161.37 | 730.3 | Upgrade
|
| Net Cash Flow | - | -856.69 | 2,843 | 35.13 | -28.34 | Upgrade
|
| Free Cash Flow | - | -620.75 | -468.56 | -323.85 | -350.52 | Upgrade
|
| Free Cash Flow Margin | - | -2062.65% | -38675.98% | -68143.75% | -894.41% | Upgrade
|
| Free Cash Flow Per Share | - | -1.69 | -1.46 | -1.18 | -1.27 | Upgrade
|
| Cash Income Tax Paid | - | 4 | -21.69 | -57.48 | -17.5 | Upgrade
|
| Levered Free Cash Flow | - | -413.65 | -267.97 | -190.87 | -715.31 | Upgrade
|
| Unlevered Free Cash Flow | - | -395.59 | -246.1 | -170.4 | -695.05 | Upgrade
|
| Change in Working Capital | - | 119.3 | 327.89 | 318.97 | 11.57 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.